PACS Group (PACS) saw its stock price soar by 18.19% during Wednesday's trading session, following the release of its impressive third-quarter financial results and optimistic full-year projections.

The healthcare operations company reported that its full-year revenue is expected to be between $5.3 billion and $5.4 billion, with adjusted EBITDA projected in the range of $480 million to $490 million. This strong financial performance has evidently boosted investor confidence in the company's growth trajectory.

Adding to the positive sentiment, PACS Group announced the completion of a restatement of previous financial statements, bringing the company current with SEC filing obligations. The company's portfolio now includes 320 healthcare operations across 17 states, with ownership of 51 facilities and purchase options on an additional 59 facilities. PACS Group also emphasized its continued pursuit of growth through leasing, acquisitions, and evaluating opportunities to acquire both high-performing and underperforming operations, signaling potential for further expansion and value creation.